生命科学资讯

Addition emerges with $100M to make gene therapies for chronic and rare diseases

3 key takeaways from the FDA’s new animal testing guidance

How the FDA could soon upend vaccine trials

Hansa’s enzyme therapy flunks Phase 3 trial in rare kidney disease

Agilent Technologies opens India Refurbishment Center to advance sustainable science and affordable innovation - Pharmabiz.com

Agilent Technologies Opens India Refurbishment Center at LEED Platinum Facility in Manesar - geneonline.com

ARS Wealth Advisors Group LLC Grows Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Assenagon Asset Management S.A. Buys 573,743 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

BioMEMS Market Hits New High | Major Giants Agilent - openPR.com

Top Exec Sells Illumina Shares in a Surprising Move! - TipRanks

GSK wins FDA approval for long-acting asthma drug

Harbour makes $90M upfront deal with Bristol Myers for new antibodies

Nektar claims phase 2 alopecia success after excluding patients who ‘should never have been enrolled’

An increase of NPY1 expression leads to inhibitory phosphorylation of PIN-FORMED (PIN) proteins and suppression of pinoid (pid) null mutants

An in vitro human vessel model to study Neisseria meningitidis colonization and vascular damages

Extracellular adenosine deamination primes tip organizer development in Dictyostelium

On CA1 ripple oscillations in rats and the reassessment of asynchronicity evidence

Endothelial Slit2 guides the Robo1-positive sympathetic innervation during heart development

Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis

Scott Davies Sells 323 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat